← Leaderboards
Yan Levitsky
Michigan State University
$180,928
Attributed
$180,928
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $50.9K · FY2019–22$100K$75K$50K$25K$0
'19
'20
'21
'22
Funding mix
By agency
NIH$180,928 · 1
By mechanism
F30$180,928 · 1
Top collaborators
No co-investigators on record.
Most similar at Michigan State University
Same institution · by research overlap
- Julia V Busik$11,064,375
- James H Geiger$2,274,208
- Babak Borhan$4,398,280
- Denis A Proshlyakov$3,699,543
- Seungik Baek$1,916,209
Others in their field
Other Emerging Leaders on “Animal Model”
- Ted Ross · University Of Georgia$71,962,304
- Leonard Freedman · Leidos Biomedical Research, Inc.$64,938,611
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$45,644,409
- Steven A. Ackerman · University Of Wisconsin-Madison$38,898,438
- Gary Fanger · Rise Therapeutics, Llc$16,982,327
Research focus
Animal ModelApoptosisApoptoticBiological PhenomenaBiophysical TechniquesBlindnessBlood CapillariesBlood LipidBlood-Retinal BarrierCarrier ProteinsCell Culture TechniquesCell InjuryCell Membrane PermeabilityCellsCeramidesChronicClinical ManagementClinical TrialsComplexComplications Of Diabetes MellitusCytochrome CDiabetes MellitusDiabeticAcid Sphingomyelinase
Grant awards (4)
Mitochondrial Ceramide and Diabetic Retinopathy$32,130
F30 · FY2022 · EY · contact PI
Mitochondrial Ceramide and Diabetic Retinopathy$50,903
F30 · FY2021 · EY · contact PI
Mitochondrial Ceramide and Diabetic Retinopathy$49,585
F30 · FY2020 · EY · contact PI
Mitochondrial Ceramide and Diabetic Retinopathy$48,310
F30 · FY2019 · EY · contact PI